Herbas VPB

Print
EN | LT
LT - Humanizuoti anti-beta7 antagonistai ir jų panaudojimas
EN - HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
C07K 16/18 (2006.01)
A61P 1/00 (2006.01)
A61P 1/04 (2006.01)
A61P 3/10 (2006.01)
A61P 5/00 (2006.01)
A61P 11/06 (2006.01)
A61P 29/00 (2006.01)
A61P 37/00 (2006.01)
A61P 37/06 (2006.01)
A61P 41/00 (2006.01)
A61P 43/00 (2006.01)
European patent
(11) Number of the document 3530673
(13) Kind of document T
(96) European patent application number 18181899.8
Date of filing the European patent application 2005-09-02
(97) Date of publication of the European application 2019-08-28
(45) Date of publication and mention of the grant of the patent 2022-03-30
(46) Date of publication of the claims translation 2022-06-10
Priority applications
(30) Number Date Country code
607377 P 2004-09-03 US
Inventors
(72)
DENNIS, Mark, S. , US
FONG, Sherman , US
Grantee
(73) Genentech, Inc. , 1 DNA Way, South San Francisco, CA 94080-4990, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Humanizuoti anti-beta7 antagonistai ir jų panaudojimas
  HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR
Last renewal fee
Payment date Validity (years) Amount
2022-08-22 18 347.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2023-09-02